Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 May;41(5):1069–1072. doi: 10.1128/aac.41.5.1069

Effect of food intake on pharmacokinetics of oral artemisinin in healthy Vietnamese subjects.

T K Dien 1, P J de Vries 1, N X Khanh 1, R Koopmans 1, L N Binh 1, D D Duc 1, P A Kager 1, C J van Boxtel 1
PMCID: PMC163852  PMID: 9145871

Abstract

The influence of food intake on the pharmacokinetics of artemisinin was studied with six healthy Vietnamese male subjects. In a crossover study, artemisinin capsules (500 mg) were administered with and without food after an overnight fast. Plasma samples were obtained up to 24 h after intake of each drug. Measurement of artemisinin concentrations was performed by high-performance liquid chromatography with electrochemical detection. Tolerance was evaluated according to subjective and objective findings, including repeated physical examinations, routine blood investigations, and electrocardiograms. Pharmacokinetics were analyzed with a noncompartmental method and with a one-compartment model. This model had either zero-order or first-order input. No statistically significant differences were found between the results of the two experimental conditions. Specifically, there were no consistent differences in parameters most likely to be affected by food intake, including absorption profile, absorption rate, bioavailability (f) (as reflected in area under the concentration time curve [AUC]), and drug clearance. Some mean +/- standard deviation parameters after food were as follows: maximum concentration of drug in serum (Cmax), 443 +/- 224 microg x liter(-1); time to Cmax, 1.78 +/- 1.2 h; AUC, 2,092 +/- 1,441 ng x ml(-1) x h, apparent clearance/f, 321 +/- 167 liter x h(-1); mean residence time, 4.42 +/- 1.31 h; and time at which half of the terminal value was reached, 0.97 +/- 0.68 h. The total amount of artemisinin excreted in urine was less than 1% of the dose. We conclude that food intake has no major effect on artemisinin pharmacokinetics. In addition, we conclude tentatively that artemisinin is cleared by the liver, that this clearance does not depend on liver blood flow (i.e., that artemisinin is a so-called low-clearance drug), and that absorption of the drug is not affected by food intake.

Full Text

The Full Text of this article is available as a PDF (268.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alin M. H., Björkman A., Ashton M. In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):635–637. doi: 10.1016/0035-9203(90)90129-3. [DOI] [PubMed] [Google Scholar]
  2. Duc D. D., de Vries P. J., Nguyen X. K., Le Nguyen B., Kager P. A., van Boxtel C. J. The pharmacokinetics of a single dose of artemisinin in healthy Vietnamese subjects. Am J Trop Med Hyg. 1994 Dec;51(6):785–790. doi: 10.4269/ajtmh.1994.51.785. [DOI] [PubMed] [Google Scholar]
  3. Gu H. M., Warhurst D. C., Peters W. Uptake of [3H] dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg. 1984;78(2):265–270. doi: 10.1016/0035-9203(84)90296-7. [DOI] [PubMed] [Google Scholar]
  4. Hassan Alin M., Ashton M., Kihamia C. M., Mtey G. J., Björkman A. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans R Soc Trop Med Hyg. 1996 Jan-Feb;90(1):61–65. doi: 10.1016/s0035-9203(96)90480-0. [DOI] [PubMed] [Google Scholar]
  5. Hassan Alin M., Björkman A., Landberg-Lindgren A., Ashton M. The effect of artemisinine, its derivatives and mefloquine against chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg. 1992 Jul-Aug;86(4):365–367. doi: 10.1016/0035-9203(92)90220-7. [DOI] [PubMed] [Google Scholar]
  6. Hien T. T., White N. J. Qinghaosu. Lancet. 1993 Mar 6;341(8845):603–608. doi: 10.1016/0140-6736(93)90362-k. [DOI] [PubMed] [Google Scholar]
  7. Klayman D. L. Qinghaosu (artemisinin): an antimalarial drug from China. Science. 1985 May 31;228(4703):1049–1055. doi: 10.1126/science.3887571. [DOI] [PubMed] [Google Scholar]
  8. Kornhauser D. M., Wood A. J., Vestal R. E., Wilkinson G. R., Branch R. A., Shand D. G. Biological determinants of propranolol disposition in man. Clin Pharmacol Ther. 1978 Feb;23(2):165–174. doi: 10.1002/cpt1978232165. [DOI] [PubMed] [Google Scholar]
  9. Lee I. S., Hufford C. D. Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther. 1990;48(3):345–355. doi: 10.1016/0163-7258(90)90053-5. [DOI] [PubMed] [Google Scholar]
  10. Leskovac V., Theoharides A. D. Hepatic metabolism of artemisinin drugs--I. Drug metabolism in rat liver microsomes. Comp Biochem Physiol C. 1991;99(3):383–390. doi: 10.1016/0742-8413(91)90261-q. [DOI] [PubMed] [Google Scholar]
  11. Li Z. L., Gu H. M., Warhurst D. C., Peters W. Effects of qinghaosu and related compounds on incorporation of [G-3H] hypoxanthine by Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg. 1983;77(4):522–523. doi: 10.1016/0035-9203(83)90129-3. [DOI] [PubMed] [Google Scholar]
  12. Melendez V., Peggins J. O., Brewer T. G., Theoharides A. D. Determination of the antimalarial arteether and its deethylated metabolite dihydroartemisinin in plasma by high-performance liquid chromatography with reductive electrochemical detection. J Pharm Sci. 1991 Feb;80(2):132–138. doi: 10.1002/jps.2600800209. [DOI] [PubMed] [Google Scholar]
  13. Nguyen D. S., Dao B. H., Nguyen P. D., Nguyen V. H., Le N. B., Mai V. S., Meshnick S. R. Treatment of malaria in Vietnam with oral artemisinin. Am J Trop Med Hyg. 1993 Mar;48(3):398–402. [PubMed] [Google Scholar]
  14. Niu X. Y., Ho L. Y., Ren Z. H., Song Z. Y. Metabolic fate of Qinghaosu in rats; a new TLC densitometric method for its determination in biological material. Eur J Drug Metab Pharmacokinet. 1985 Jan-Mar;10(1):55–59. doi: 10.1007/BF03189697. [DOI] [PubMed] [Google Scholar]
  15. Thaithong S., Beale G. H. Susceptibility of Thai isolates of Plasmodium falciparum to artemisinine (qinghaosu) and artemether. Bull World Health Organ. 1985;63(3):617–619. [PMC free article] [PubMed] [Google Scholar]
  16. Welling P. G. Interactions affecting drug absorption. Clin Pharmacokinet. 1984 Sep-Oct;9(5):404–434. doi: 10.2165/00003088-198409050-00002. [DOI] [PubMed] [Google Scholar]
  17. Yamaoka K., Nakagawa T., Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1978 Apr;6(2):165–175. doi: 10.1007/BF01117450. [DOI] [PubMed] [Google Scholar]
  18. de Vries P. J., de Hooge P., Hoekstra J. B., van Hattum J. Blunted postprandial reaction of portal venous flow in chronic liver disease, assessed with duplex Doppler: significance for prognosis. J Hepatol. 1994 Dec;21(6):966–973. doi: 10.1016/s0168-8278(05)80603-8. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES